ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company announced the appointment of Dr. Andrew Cavey, as its Chief Executive Officer effective...
Eli Lilly and Company announced the successful completion of its acquisition of POINT Biopharma Global Inc., a radiopharmaceutical company with a pipeline of clinical...
